Comparative efficacy of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.2% ophthalmic solution evaluated by patient preference

Overview of attention for article published in Clinical Ophthalmology, October 2012

Altmetric Badge

Mentioned by

facebook: 1 Facebook page

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 21 Mendeley

Summary Facebook Dimensions citations

So far, Dimensions has found 18 publications that cite this research output.

18

The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.

Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops Vs Olopatadine Hydrochloride 0.2% Bak-Preserved Eye Drops in Patients with Allergic Conjunctivitis

Article in Clinical Ophthalmology (November 2023)

Comparative Clinical Trial to Evaluate the Efficacy and Toxicity of Bepostastine Besilate 1,5% Preservative-free vs Olopatadine Hydrochloride 0,2 Bak-preserved in Patients With Allergic Conjuctivitis

Preprint in Research Square (May 2023)

Therapeutic Targets in Allergic Conjunctivitis

Article in Pharmaceuticals (April 2022)